LifeMD Inc(LFMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:39 PM ET (Korea 9/12 05:39)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.52 | Insider Own | 18.67% | Shs Outstand | 47.8M | Perf Week | - |
| Market Cap | 0.15B | Forward P/E | - | EPS next Y | 82.37% | Insider Trans | - | Shs Float | 39.2M | Perf Month | -7.29% |
| Enterprise Value | 0.13B | PEG | - | EPS next Q | -0.14 | Inst Own | 45.06% | Short Float | 18.47% | Perf Quarter | -37.76% |
| Income | -0.02B | P/S | 0.72 | EPS this Y | -307.43% | Inst Trans | 11.54% | Short Ratio | 7.86 | Perf Half Y | -22.49% |
| Sales | 0.20B | P/B | 18.31 | EPS next 5Y | -15.28% | ROA | -31.25% | Short Interest | 7.24M | Perf YTD | -10.56% |
| Book/sh | 0.17 | P/C | 5.85 | EPS past 3/5Y | 47.57% 44.86% | ROE | -674.34% | 52W High | -58.33% ($7.32) | Perf Year | -48.22% |
| Cash/sh | 0.52 | P/FCF | - | Sales past 3/5Y | 17.69% 39.08% | ROIC | -160.04% | 52W Low | 19.14% ($2.56) | Perf 3Y | -34.97% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -143.95% | Gross Margin | 82.43% | Volatility(W/M) | 4.34% 4.55% | Perf 5Y | -57.52% |
| Dividend TTM | - | EV/Sales | 0.63 | Sales Y/Y TTM | -16.73% | Oper. Margin | -9.35% | ATR (14) | 0.17 | Perf 10Y | 144% |
| Dividend Ex-Date | - | Quick Ratio | 0.84 | EPS Q/Q | -156.23% | Profit Margin | -11.92% | RSI (14) | 38.3 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.9 | Sales Q/Q | -24.01% | SMA20 | -4.05% ($3.18) | Beta | 1.98 | Target Price | $8.12 |
| Payout | - | Debt/Eq | 0.76 | Earnings | 2026/8/5 | SMA50 | -17.62% ($3.7) | Rel Volume | 1.41 | Prev Close | $3.03 |
| Employees | 389 | LT Debt/Eq | 0.67 | EPS/Sales Surpr. | -9.81% -3.78% | SMA200 | -20.42% ($3.83) | Avg Volume(3M) | 0.92M | Price | $3.05 |
| IPO | 2003/10/21 | Option/Short | Yes/Yes | Trades | 5744 | Volume | 1,298,993 | Change | 0.66% |
Company
LFMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
LifeMD is a US-based direct-to-consumer telehealth company. It has positioned weight management (anti-obesity medications) as its core growth driver and operates a digital healthcare platform that is expanding its care categories to include men's health, women's health, and behavioral health. The company is known for its integrated model that combines subscription-based virtual consultations with prescription and medication delivery services.
Over the past 1 year, on the lower side
58% below its 1-year high.
LFMD has weak earning power
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -307.4% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -35.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 45.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
BUYO 0.00%
SQLV 0.00%
KOMP 0.00%
IWC 0.00%
JPSE 0.00%It ranks #4 in the industry
Based on market cap of $147M.
LFMD $147M PER -
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is LFMD?
LFMD belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of LFMD?
The market cap of LFMD is approximately $147M, ranking 4,317 within its sector.
What is the 52-week high and low for LFMD?
LFMD has recorded a 52-week high of $7.32 and a low of $2.56.
